Other pharmaceutical companies may be assessing the impact on their portfolio and reviewing their current R&D pipeline and priorities

Here's how to navigate them gracefully: Work Lunches & Dinners Strategy: Suggest restaurants with GLP-1-friendly options when possible Order confidently without over-explaining ("I'll have the grilled salmon") If asked about small portions: "Not very hungry" or "Had a late breakfast" Focus on conversation, not your plate Birthday Dinners & Celebrations Strategy: Eat a small protein snack before arriving Order an appetizer as your entree if you want When cake arrives: take a small slice, have a bite or two, participate in the celebration No one's monitoring your plate Family Gatherings Strategy: Take small portions of everything you want to try Eat protein first If family comments on your eating: "My appetite isn't what it used to be" or "I'm pacing myself" Offer to bring a dish you know you can eat Date Nights Strategy: Choose restaurants with varied menus (options for both of you) Order what works for you without apologizing Share appetizers or desserts (have a taste, not half) Focus on the company, not the food volume Handling Comments About Your Eating Inevitably, someone will notice you're eating less or differently

Developed by Eli Lilly, this synthetic peptide consists of 39 amino acids and is engineered with a C20 fatty diacid modification, which extends its half-life and enables convenient once-weekly subcutaneous dosing
"So happy to hear about ALL of the health benefits
Some patients report improved mood while on these medications, but results vary
#pharma #biotech #biopharma #pharmaceuticals To view or add a comment, sign in Small Molecules Enter the GLP-1 Track: The Path to Breakthrough and Coexistence for Peptide Products With oral convenience and controllable production costs, small-molecule GLP-1 therapeutics have disrupted the GLP-1 market rapidly